2 drug(s) with this reaction
8,610 total reports
Drug Dose Omission By Device has been reported as an adverse reaction across 2 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 8,610 adverse event reports mention drug dose omission by device in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with drug dose omission by device, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have drug dose omission by device listed in their FDA adverse event reports, sorted by report count:
In addition to drug dose omission by device, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
2 drug(s) manufactured by Amgen Inc have drug dose omission by device listed in their FDA adverse event reports: ERENUMAB-AOOE, PEGFILGRASTIM.
There are a combined 8,610 reports of drug dose omission by device across 2 Amgen Inc drug(s) in the FDA adverse event database.